Stock Report

Download full stock data and analysis for free Last Updated: 06-Sep-2026

Stock Rating

Is this stock worth it? Our ratings reveal the truth.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Clear All

AnPac Bio-Medical Science - ADR Key Ratios

Stock Card factsheet share-fund-plan-icon

$3.80

up-down-arrow $-36.54 (-90.58%)

As on 21-Jul-2023 09:30EDT

Market cap

info icon

$27 Mln

Revenue (TTM)

info icon

$12 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

5.7

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -93.17 -89.85 -33.04 3.56 16.20
EBIT -44.87 0.36 6.50 1.82 -170.36
Net Profit -66.77 -2.10 16.34 -0.65 -191.78
EPS -- -- -- -- --
Book Value -- -- -- -- --
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsDec-22Dec-21Dec-20
EBIT-Margin info -580.76-593.39-698.59-589.60-454.07
Net Margin info ---410.37------
Return on equity info 5,954.063,809.481,140.0115,485.111,237.08
Return on Capital info -604.55-583.76-742.69-593.90-477.07
Return on Assets info -184.39-163.98-191.92-204.62-156.64
Debt to Equity (x) info -----0.90-7.502.79

Profitability

View Detailed Peer Comparison

ROCE

-742.69

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
AnPac Bio-Medical Science - ADR
-742.69
-593.90
-477.07
-776.83
-328.28
Peer Median
--
--
--
--
--
ROE

1,140.01

--

Profit after tax / Average Net worth * 100

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
AnPac Bio-Medical Science - ADR
1,140.01
15,485.11
1,237.08
529.75
655.44
Peer Median
--
--
--
--
--
ROA

-191.92

--

Profit after tax / Average Total assets * 100

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
AnPac Bio-Medical Science - ADR
-191.92
-204.62
-156.64
-192.20
-74.51
Peer Median
--
--
--
--
--
EBIT Margin

-698.59

--

Operating profit (EBIT) / Net Sales * 100

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
AnPac Bio-Medical Science - ADR
-698.59
-589.60
-454.07
-821.41
-403.29
Peer Median
--
--
--
--
--
Net Margin

-860.16

--

Net profit / Total Income (Net sales plus other income) * 100

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
AnPac Bio-Medical Science - ADR
-860.16
-667.67
-392.83
-937.03
-410.37
Peer Median
--
--
--
--
--

Growth

View Detailed Peer Comparison

Revenue Growth

-0.33

--

Year on year growth in net sales

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
AnPac Bio-Medical Science - ADR
-0.33
-0.12
0.89
0.06
0.80
Peer Median
--
--
--
--
--
EBIT Growth

20.66

--

Year on year growth in operating profit (EBIT)

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
AnPac Bio-Medical Science - ADR
20.66
-13.87
-4.54
-115.50
-6.73
Peer Median
--
--
--
--
--
Net Profit Growth

13.73

--

Year on year growth in profit after tax

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
AnPac Bio-Medical Science - ADR
13.73
-49.06
20.72
-141.59
-7.64
Peer Median
--
--
--
--
--

Solvency

View Detailed Peer Comparison

Debt to Equity

-0.90

--

Total debt / Net worth

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
AnPac Bio-Medical Science - ADR
-0.90
-7.50
2.79
-2.41
-1.16
Peer Median
--
--
--
--
--
Short term debt to equity ratio

-0.42

--

(Short term borrowings / Net worth)

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
AnPac Bio-Medical Science - ADR
-0.42
-7.50
2.79
-2.41
-1.16
Peer Median
--
--
--
--
--
Current Ratio

0.32

--

Current Assets / Current Liabilities and Provisions

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
AnPac Bio-Medical Science - ADR
0.32
0.37
0.49
0.33
0.29
Peer Median
--
--
--
--
--
Quick Ratio

0.32

--

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
AnPac Bio-Medical Science - ADR
0.32
0.37
0.48
0.33
0.29
Peer Median
--
--
--
--
--
Interest Coverage

-225.57

--

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
AnPac Bio-Medical Science - ADR
-225.57
-24.91
-81.48
-34.14
-44.69
Peer Median
--
--
--
--
--

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

46.01

--

Debtors outstanding / Net Sales * 100

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
AnPac Bio-Medical Science - ADR
46.01
39.20
44.22
17.06
29.44
Peer Median
--
--
--
--
--
Asset Turnover

0.22

--

Sales / Average Total Assets

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
AnPac Bio-Medical Science - ADR
0.22
0.31
0.40
0.21
0.18
Peer Median
--
--
--
--
--
Receivable days

190.93

--

Average Debtors / Sales * 365

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
AnPac Bio-Medical Science - ADR
190.93
163.68
97.23
81.97
94.22
Peer Median
--
--
--
--
--
Inventory Days

34.48

--

Average Inventory / Sales * 365

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
AnPac Bio-Medical Science - ADR
34.48
25.55
14.96
11.33
9.72
Peer Median
--
--
--
--
--
Payable days

238.38

--

Average Creditors / Cost of goods sold * 365

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
AnPac Bio-Medical Science - ADR
238.38
154.81
94.02
103.23
131.33
Peer Median
--
--
--
--
--
Cash Conversion Cycle

-12.97

--

Receivable Days + Inventory Days - Payable Days

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
AnPac Bio-Medical Science - ADR
-12.97
34.42
18.18
-9.93
-27.39
Peer Median
--
--
--
--
--
loading...
loading...